| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT06113302 A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-09 | NCT06113302 A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic… |
Enrollment reduced: 40 -> 10 participants |
| 2026-06-05 | NCT07523009 CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA |
overall status: "Not Yet Recruiting" → "Withdrawn" |
| 2026-06-05 | NCT07523009 CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA |
critical why stopped: null → "The registration of this research plan was incorrect. A new registration has been re-applied for." |
| 2026-06-05 | NCT07523009 CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA |
Enrollment reduced: 43 -> 0 participants |
| 2026-06-05 | NCT07522996 Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA |
overall status: "Not Yet Recruiting" → "Withdrawn" |
| 2026-06-05 | NCT07522996 Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA |
critical why stopped: null → "The registration of this research plan was incorrect. A new registration has been re-applied for." |
| 2026-06-05 | NCT07522996 Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA |
Enrollment reduced: 90 -> 0 participants |
| 2026-05-24 | NCT07463950 A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical… |
date change Primary completion pushed: 2026-05-04 -> 2026-06-09 |
| 2026-05-24 | NCT07463950 A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical… |
date change Completion pushed: 2026-05-04 -> 2026-06-09 |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
Enrollment reduced: 20 -> 1 participants |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
date change Primary completion moved earlier: 2027-12-31 -> 2026-01-23 |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
date change Completion moved earlier: 2027-12-31 -> 2026-10-15 |
| 2026-05-21 | NCT01962636 Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for… |
Trial terminated — check why_stopped for reason |
| 2026-05-21 | NCT01962636 Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for… |
critical why stopped: null → "No longer a research question to answer." |
| 2026-05-21 | NCT01962636 Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for… |
date change Primary completion moved earlier: 2027-02 -> 2026-05-14 |
| 2026-05-21 | NCT01962636 Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for… |
date change Completion moved earlier: 2028-02 -> 2026-05-14 |
| 2026-05-15 | NCT07566377 Cord Blood Transplantation in Children and Young Adults With Blood Cancer |
Trial arms changed: 6 -> 2 |
| 2026-05-15 | NCT07566377 Cord Blood Transplantation in Children and Young Adults With Blood Cancer |
Trial sites reduced: 7 -> 1 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07636486 Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological… | Phase 2/3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07381556 | Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care… | Alopecia Areata(AA) | Recruiting |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT04877288 | A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney… | Renal Allograft Recipients | Recruiting |
| NCT04064060 | A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other… | Myelodysplastic Syndromes (MDS) | Recruiting |
| NCT06658002 | Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A | Fungal Keratitis | Recruiting |
| NCT07345000 | A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe… | Treatment-naïve Severe Aplastic Anemia | Not Yet Recruiting |
| NCT04547049 | A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From… | Leukemia | Active, Not Recruiting |
| NCT07548671 | Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA | Transfusion-dependent Non-severe Aplastic Anemia | Not Yet Recruiting |
| NCT05949684 | ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants… | Myelodysplastic Syndromes | Active, Not Recruiting |
| NCT05600426 | A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients… | Severe Aplastic Anemia | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT07366801 | Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell… | Acute Myeloid Leukemia, Relapsed | Recruiting |
| NCT07539779 | Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With… | Luspatercept | Not Yet Recruiting |
| NCT07636486 | Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological… | Luspatercept | Not Yet Recruiting |
| Phase 2 | |||
| NCT04143724 | Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta… | Beta-Thalassemia | Recruiting |
| NCT06013423 | Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in… | Acute Leukemia of Ambiguous Lineage | Recruiting |
| NCT04304820 | Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive… | Severe Aplastic Anemia | Recruiting |
| NCT03970096 | Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant… | Acute Leukemia | Recruiting |
| NCT07096297 | Luspatercept + Darbepoetin in MDS | MDS (Myelodysplastic Syndrome) | Recruiting |
| NCT05664737 | A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to… | Anemia | Recruiting |
| NCT06788691 | Luspatercept for Clonal Cytopenias of Uncertain Significance | CCUS Clonal Cytopenia of Undetermined Significance | Recruiting |
| NCT01624805 | Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or… | Aplastic Anemia | Recruiting |
| NCT06517875 | Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion… | Primary Myelofibrosis | Recruiting |
| NCT05946772 | Cyclosporine In Takotsubo Syndrome | Takotsubo Cardiomyopathy | Recruiting |
| NCT04888741 | Methods of T Cell Depletion Trial (MoTD) | Acute Myeloid Leukemia | Recruiting |
| NCT07566377 | Cord Blood Transplantation in Children and Young Adults With Blood Cancer | Acute Myelogenous Leukemia | Recruiting |